Position in BMY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,457,079
-$1,138,732 QoQ
Shares Held
77,353
-16.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#579
of 2,506 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $57,599,993 across 10 Drug Manufacturers - General names. BMY ranks #5 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
75,730 | $19,233,148 | |
| 2 | LLY |
ELI LILLY & Co
|
9,795 | $11,748,417 | |
| 3 | MRK |
Merck & Co., Inc.
|
62,572 | $8,040,502 | |
| 4 | ABBV |
AbbVie Inc.
|
26,085 | $6,564,029 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
77,353 | $4,457,079 | |
| 6 | BIIB |
Biogen Inc.
|
12,859 | $2,778,315 | |
| 7 | PFE |
Pfizer Inc
|
75,558 | $1,819,436 | |
| 8 | AMGN |
Amgen Inc
|
4,792 | $1,735,279 |
All Filings in BMY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,457,079 | 77,353 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $5,595,811 | 92,264 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $5,186,708 | 96,157 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,461,555 | 32,407 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,038,516 | 22,435 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,600,194 | 26,237 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,546,237 | 27,338 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,456,325 | 28,147 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $772,873 | 18,610 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $492,083 | 9,074 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $343,828 | 6,701 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $400,940 | 6,908 | Shares | Sole | 2023-11-01 | |
| No filing history on record for this holder in this stock. | ||||||